A Study to Assess the Safety and Efficacy of a New Influenza Candidate Vaccine MVA-NP+M1 In Healthy Adults
NCT00993083
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
27
Enrollment
OTHER
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
MVA-NP+M1
Sponsor
University of Oxford
Collaborators
[object Object]